Overall, our findings demonstrated that MetS increased the levels of sRANKL, SOST, DKK-1, FGF-23, and PTH at the osteocyte level, translating into the dysregulation of the bone formation and resorption in the animals. Here, SOST is linked to metabolic syndrome.